Antibiotic-resistant bacteria inhibited by extracts and fractions from Brazilian marine sponges;Bactérias resistentes a antibióticos inibidas por extratos e frações de esponjas marinhas do Brasil

Revista Brasileira de Farmacognosia

Volumn 20, Issue 2, 2010, Pages 267-275

  Marinho, Palloma R ^a   Muricy, Guilherme R S ^a   Silva, Mara F L ^a   de Marval, Marcia Giambiagi ^a   Laport, Marinella S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antibacterial activity; Antibiotic resistant bacteria; Marine sponges; Petromica citrina

Indexed keywords

ANTIINFECTIVE AGENT; PETROMICA CITRINA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOASSAY; BRAZIL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PETROMICA CITRINA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SYNTHESIS; SCREENING TEST; SPONGE (PORIFERA); STAPHYLOCOCCUS AUREUS;

EID: 77954698228     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2010000200022     Document Type: Article

References (40)

1. Amade PG, Chariou G, Baby C, Vacelet J 1987. Antimicrobial activity of marine sponges of Mediterranean. Sea Mar Biol 94: 271-275.
2. Amade PH, Pesando D, Chevolot L 1982. Antimicrobia activity of marine sponges from French Polynesia and Brittany. Mar Biol 70: 223-228.
3. Aneiros A, Garateix A 2004 Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J Chromatogr B 803: 41-53.
4. Ausubel FM, Brent R, Kingston RE, Moore DD, Sidman JG, Smith K 1994-1997. Current Protocols in Molecular Biology. Vol 2, ch 10. New York: Wiley Interscience, p. 10.0.5-10.20.13.
5. Becerro MA, Thacker RW, Turon X, Uriz MJ, Paul VJ 2003.Biogeography of sponge chemical ecology: comparisons of tropical and temperate defenses. Oecologia 135: 91-101.
6. Bergquist P, Bedford JJ 1978. The incindence of antibacterial activity in marine Demospongiae: systematic and geographical considerations. Mar Biol 46: 215-221.
7. Berlinck RGS, Hajdu E, Rocha RM, Oliveira JHHL, Hernandez ILC, Seleghim MHR, Granato AC, Almeida EVR, Nunez CV, Muricy G, Peixinho S, Pessoa C, Moraes MO, Cavalcanti BC, Nascimento GGF, Thiemann O, Silva M, Souza AO, Silva CL, Minarini PRR 2004. Challenges and rewards of research in marine natural products chemistry in Brazil. J Nat Prod 67: 510-522.
8. Bernan VS, Roll DM, Ireland CM, Greenstein M, Maiese WM, Steinberg DA 1993. A study on the mechanism of action of sceptrin, an antimicrobial agent isolated from the South Pacific sponge Agelas mauritiana. J Antimicrob Chemother 32: 539-550.
9. Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR 2007. Marine natural products. Nat Prod Rep 24: 31-86.
10. Burgess JG, Jordan EM, Bregu M, Mearns-Spragg A, Boyd KG 1999. Microbial antagonism: a neglected avenue of natural products research. J Biotechnol 70: 27-32.
11. CLSI (Clinical and Laboratory Standards Institute) 2006. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. Seventh Edition (M7-A7). NCCLS, Wayne PA.
12. Cos P, Vlietinck AJ, Berghe DV, Maes L 2006. Anti-infective potential of natural products: How to develop a stronger in vitro "proof-of-concept". J Ethnopharmacol 106: 290-302.
13. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, Sentry Partcipants Group 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32: S114-132.
14. Farr BM 2006. What to think if the results of the National Institutes of Health Randomized Trial of Methicillin Resistant Staphylococcus aureus and Vancomycin Resistant Enterococcus Control Measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 27: 1096-1106.
15. Gerwick WH 1987. Drugs from the sea: The search continues. J Pharm Technol 3:136-141.
16. Giambiagi-deMarval M, Mafra MA, Penido EGC, Bastos MCF 1990. Distinct groups of plasmids correlated with bacteriocin production in Staphylococcus aureus. J Gen Microbiol 136: 1591-1599.
17. Goldrick BA 2004. Emerging infections. Am J Nurs 104: 50-51.
18. Isenberg HD 1992. Clinical Microbiology Procedures Handbook. Vol 1, Sec 5.16. Washington, DC: ASM.
19. Kobayashi M 2000. Search for biologically active substances from marine sponges. In: Fusetani N (ed) Drugs from the Sea. Basel: Karger, p.46-58.
20. Laport MS, Castro ACD, Villardo A, Lemos JAC, Bastos MCF, Giambiagi-deMarval M 2001. Expression of the Major Heat Shock Proteins DnaK and GroEL in Streptococcus pyogenes: A Comparison to Enterococcus faecalis and Staphylococcus aureus. Curr Microbiol 42: 264-268.
21. Laport MS, Santos OCS, Muricy G 2009. Marine sponges: potential sources of new antimicrobial drugs. Curr Pharm Biotechnol 10: 86-105.
22. Mayer AM, Hamann MT 2004. Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol (NY) 6: 37-52.
23. Monks NR, Lerner C, Henriques AT, Farias FM, Schapoval EES, Suyenaga ES, Rocha AB, Schwartsmann G, Mothes B 2002. Anticancer, antichemotactic and antimicrobial activities of marine sponges collected off the coast of Santa Catarina, Southern Brazil. J Exp Mar Biol Ecol 281: 1-12.
24. Monteiro LC, Muricy G 2004. Patterns of sponge distribution in Cagarras Arquipelago, Rio de Janeiro, Brazil. J Mar Biol Ass UK 84: 681-687.
25. Moura RM, Queiroz AF, Fook JM, Dias AS, Monteiro NK, Ribeiro JK, Moura GE, Macedo LL, Santos EA, Sales MP 2006. CvL, a lectin from the marine sponge Cliona varians: Isolation, characterization and its effects on pathogenic bacteria and Leishmania promastigotes. Comp Biochem Physiol A Mol Integr Physiol 145: 517-523.
26. Munro MH, Blunt JW, Dumdei EJ, Hickford SJ, Lill RE, Li S, Battershill CN, Duckworth AR 1999. The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol 70: 15-25.
27. Muricy G, Hajdu E, Araújo FV, Hagler NA 1993. Antimicrobial activity of Southwestern Atlantic shallow-water marine sponges (Porifera). Sci Mar 57: 427-432.
28. National Nosocomial Infections Surveillance (NNIS) System Report 2004. Data summary from January 1992 through June 2004. Am J Infect Control 32: 470-485.
29. Pawlik JR, Chanas B, Toonen RJ, Fenical W 1995. Defenses of caribbean sponges against predatory reef fish. I. Chemical deterrency. Mar Ecol Prog Ser 127: 183-194.
30. Rangel M, Sanctis B, Freitas JC, Polatto JM, Granato AC, Berlinck RGS, Hajdu E 2001 Cytotoxic and neurotoxic activities in extracts of marine sponges (Porifera) from southeastern Brazilian coast. J Exp Mar Biol Ecol 262: 31-40.
31. Rice LB 2006. Antimicrobial resistance in Gram-positve bacteria. Am J Infect Control 34: S11-19.
32. Seleghim MHR, Lira SP, Kossuga MH, Batista T, Berlinck RGS, Hajdu E, Muricy G, Rocha, RM, Nascimento GGF, Silva M, Pimenta EF, Thiemann OH, Oliva G, Cavalcanti BC, Pessoa C, Moraes MO, Galetti FCS, Silva CL, Souza AO, Peixinho S 2007. Antibiotic, cytotoxic and enzyme inhibitory activity of crude extracts from Brazilian marine invertebrates. Rev Bras Farmacogn 17: 287-318.
33. Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH 2005. Marine sponges as pharmacy. Mar Biotechnol (NY) 7: 142-162.
34. Thompson JE, Walker RP, Falkner DJ 1985. Screening and bioassays for biologically active substances from forty marine sponges from San Diego, California, USA. Mar Bio 88: 11-21.
35. Thoms C, Schupp PJ 2007. Chemical defense strategies in ponges: a review. In: Custódio, MR, Lôbo-Hajdu G, Hajdu E, Muricy G (eds) Porifera Research Biodiversity, Innovation and Sustainability. Rio de Janeiro: Série Livros 28, Museu Nacional, p. 627-637.
36. Torres YR, Berlink RGS, Nascimento GGF, Fortier SC, Pessoa C, Moraes MO 2002. Antibacterial activity against resistant bacteria and cytotoxicity of four alkaloid toxins isolated from the marine sponge Arenosclera brasiliensis. Toxicon 40: 885-891.
37. Uriz MJ, Martin D, Turon X, Ballesteros E, Hughes R, Acebal C 1991. Anapproach to the ecological significance of chemically-mediated bioactivity in Mediterranean benthic communities. Mar Ecol Progr Ser 70: 175-188.
38. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y 2003 Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9: 1415-1422.
39. Wulff JL 2006. Sponge systematics by starfish: predators distinguish cryptic sympatric species of Caribbean fire sponges, Tedania ignis and Tedania klausi n. sp. (Demospongiae, Poecilosclerida). Biol Bull 211: 83-94.
40. Zetola N, Francis JS, Nuermberger EL, Bishai, WR 2005. Community acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5: 275-286.